Comparison of Safety and Efficacy of Streptokinase and Tenecteplase in Patients of Myocardial Infarction

Journal Title: IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) - Year 2019, Vol 18, Issue 1

Abstract

Myocardial infarction is a major cause of mortality and morbidity worldwide. STEMI [ST segment elevation myocardial infarction] is a medical emergency condition. Reperfusion therapy like PCI [Percutaneous Coronary Intervention] is the gold standard for an early management of STEMI, which is better replaced by thrombolytic therapy. Thrombolytics available to treat STEMI include streptokinase (SK), urokinase (u-PA), alteplase (rt-PA), reteplase (r-PA), tenecteplase (TNK-tPA), lanoteplase.[3] Successful reperfusion therapy mainly depends upon the choice of thrombolytic agent. The aim of the study was to compare the safety and efficacy of Streptokinase and Tenecteplase in patients with acute ST segment elevation myocardial infarction. Time taken for drug administration after onset of symptoms and to assess the safety and efficacy of thrombolytics. Prospective observational study conducted for 6 months among 70 patients in cardiac care unit in Rajiv Gandhi Institute of medical sciences. Data was collected from the patients who are diagnosed with ST segment elevated myocardial infarction and who are prescribed either with streptokinase or tenecteplase. Microsoft excel was used for recording and analysing the data of recruited subjects. Descriptive statistics mean was used to calculate the average age and length of stay. Graph pad prism version 7.03(Chi-square test) was used to assess the level of significance between various parameters between the streptokinase and tenecteplase. Elderly patients more than 45 years and males were more prone to STEMI. As window period increases the thrombolytic efficacy decreases. The safety and efficacy were more for tenecteplase when compared to streptokinase. Hospital stay was increased for the streptokinase treated patients. Tenecteplase had minimum occurrence of ADR’s, greatest ST segment resolution, better symptomatic relief when compared to streptokinase. So that streptokinase was completely replaced by tenecteplase, further studies may require in cost reduction. Tenecteplase was the most safest and efficacious thrombolytic drug when compared to streptokinase in the treatment of STEMI. Co-morbidities did not affect the ST segment resolution in both thrombolytic drugs. The thrombolytic drug should be administered <2 hours of onset of symptoms for better resolution.

Authors and Affiliations

ChandraBabu . S, Gopinath. Chakka, Giri Raja Sekhar. Dornadula, Poojitha. Gundlapalli, Ramya. Nuthalapati, Yamuna. Manupoti

Keywords

.

Related Articles

Fibrous Dysplasia- A review Article

Objective: To collected and concluded a literature review on the diagnosis and management of facial fibrous dysplasia in head and neck region. Materials And Methods: The review was searched and collected from many source...

Comparative Assessment of Lung Function Using Peak Expiratory Flow Rate (PEFR) Between Tobacco Smoking And Non Smoking Students of The University of Jos

Tobacco smoking in the form of cigarette is a common habit prevalent among undergraduates in higher institutions. Chronic tobacco smoking remains the primary risk factor for chronic obstructive pulmonary disease (COPD)....

The Study of Sciatic Nerve Based on Its Morphometric Measurements And It's Variations In Rayalaseema Region.

Introduction:Sciatic nerve is the thickest and longest nerve in the human body, consists mostly of lumbosacral fibres consisting L4, L5, S1, S2, S3, they are both sensory and motor. Sciatica has been torturing mankind fo...

An Assessment of the Level of Implementation and Impact of the National Health Insurance Scheme (NHIS) on the Health Care System in Yobe State, North-Eastern Nigeria

Background: Over the decades, Health Insurance Schemes have gained popularityas an acceptable solution to health care financing. The objective of this study was to assess the level of implementation and impact of the Nat...

Download PDF file
  • EP ID EP441047
  • DOI 10.9790/0853-1801121418.
  • Views 55
  • Downloads 0

How To Cite

ChandraBabu . S, Gopinath. Chakka, Giri Raja Sekhar. Dornadula, Poojitha. Gundlapalli, Ramya. Nuthalapati, Yamuna. Manupoti (2019). Comparison of Safety and Efficacy of Streptokinase and Tenecteplase in Patients of Myocardial Infarction. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS), 18(1), 14-18. https://europub.co.uk./articles/-A-441047